22065-49-2

Upstream product

• 135-02-4 ortho-anisaldehyde 
• 5274-70-4 3-nitrosalicylic aldehyde 
• 74-88-4 methyl iodide 

Downstream Products

• 40751-88-0 2-methoxy-3-nitrobenzoic acid 
• 115820-61-6 (4R,5S)-3-[(2R,3R)-3-Hydroxy-3-(2-methoxy-3-nitro-phenyl)-2-methyl-propionyl]-4-methyl-5-phenyl-oxazolidin-2-one 
• 115889-52-6 (4R,5S)-3-[(2S,3S)-3-Hydroxy-3-(2-methoxy-3-nitro-phenyl)-2-methyl-propionyl]-4-methyl-5-phenyl-oxazolidin-2-one 
• 115889-51-5 (4R,5S)-3-[(2S,3R)-3-Hydroxy-3-(2-methoxy-3-nitro-phenyl)-2-methyl-propionyl]-4-methyl-5-phenyl-oxazolidin-2-one 
• 346705-19-9 (2-Methoxy-3-nitrophenyl)-N-methylmethanamine Hydrochloride 
• 1341231-06-8 C₁₈H₁₉NO₄ 
• 1389311-71-0 2-(2-hydroxybenzoyl)-3-(3-nitro-2-methoxyphenyl)-4H-furo[3,2-c]chromen-4-one 
• 5274-70-4 3-nitrosalicylic aldehyde 

Relevant academic research and scientific papers

TYK2 INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.

QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE RECEPTORS

Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided: wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description. Methods of preparation and uses thereof in therapy, particularly for CNS disorders such as depression or anxiety, are also disclosed.

4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use

Compounds of formula I are useful in treating diseases prevented by or ameliorated with α1A agonists. Also disclosed are α1A agonist compositions and a method of activating α1 adrenoceptors in a mammal.